Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jennifer Law"'
Autor:
Jing Wang, Connie J. Eaves, Lawrence K. Lee, Jennifer Law, Kristen Reipas, Sandra E. Dunn, Pauline Johnson, Anna L. Stratford, Isabelle M. Berquin, Afshin Raouf, Karen To, Alastair H. Davies, Abbas Fotovati, Hans-Dieter Royer, Arezoo Astanehe, Kaiji Hu
Publikováno v:
Cancer Research. 70:2840-2851
Y-box binding protein-1 (YB-1) is an oncogenic transcription/translation factor expressed in >40% of breast cancers, where it is associated with poor prognosis, disease recurrence, and drug resistance. We questioned whether this may be linked to the
Autor:
Mohamed Salla, N. V. Volodko, Victor C. Yu, Shairaz Baksh, John R. Mackey, Jennifer Law, Yoke Wong, Le Luong, Chong Teik Tan, Orysya Svystun, Alaa Zare, Jonathan Lim, Kayla Flood, Yu-Chin Su, Jason R.B. Dyck, Miranda Sung
Publikováno v:
The Journal of Biological Chemistry
Background: MOAP-1 is a pro-apoptotic protein. Results: MOAP-1 expression is reduced in cancers and high expression correlated with increased patient survival. MOAP-1 can associate with tubulin and modulate tubulin stability. Furthermore, loss of the
Autor:
Robert Ian Nicholson, Joan M. Carboni, Eugene Park, Jennifer Law, Sandra E. Dunn, Julia Margaret Wendy Gee, Kaiji Hu, Anna L. Stratford, Michael Pollak, Michelle. Y. C. Wang, Hamid Masoudi, Pauline Finlay, Helen E. Jones, Marco M. Gottardis, Golareh Habibi
Publikováno v:
Cancer research. 68(24)
Drugs that target the insulin-like growth factor-I receptor (IGF-IR) and/or insulin receptor (IR) are currently under investigation for a variety of malignancies including breast cancer. Although we have previously reported that IGF-IR expression in
Autor:
Jennifer Law, Sandra E. Dunn, Hamid Masoudi, Samuel Leung, Karen A. Gelmon, Torsten O. Nielsen, David G. Huntsman, Michael Pollak, Golareh Habibi, Dmitry Turbin
Publikováno v:
Breast Cancer Research : BCR
Introduction: Gene expression analysis is used to subtype breast cancers such that the most aggressive tumors are identified, but translating this into clinical practice can be cumbersome. Our goal is to develop a universal biomarker that distinguish
Autor:
Stephane Flibotte, Aly Karsan, Karen A. Gelmon, Jennifer Law, Dorothy A. Harrison, Philip Switzer, Timothy D. Veenstra, Moira Stillwell, Bernhard J. Eigl, Thomas P. Conrads, Malcolm Hayes, Patricia Hassell, Zhen Xiao
Publikováno v:
Clinical chemistry. 51(8)
Currently available serum tumor markers lack sufficient specificity and sensitivity as stand-alone diagnostic or screening tests (1). Nevertheless, these assays are used extensively because of a lack of better alternatives. To accelerate the discover
Publikováno v:
Breast Cancer Research : BCR
Introduction Triple-negative breast cancer (TNBC) high rate of relapse is thought to be due to the presence of tumor-initiating cells (TICs), molecularly defined as being CD44high/CD24-/low. TICs are resilient to chemotherapy and radiation. However,
Autor:
Arezoo Astanehe, Martin E. Gleave, Jennifer Law, Sandra E. Dunn, Connie J. Eaves, Karen Lambie, Michelle. Y. C. Wang, Karen To, Yvonne Y. Li, Jaspreet Dhillon, Steven J.M. Jones
Publikováno v:
PLoS ONE, Vol 5, Iss 9 (2010)
PLoS ONE
PLoS ONE
The Y-box binding protein-1 (YB-1) is an oncogenic transcription/translation factor that is activated by phosphorylation at S102 whereby it induces the expression of growth promoting genes such as EGFR and HER-2. We recently illustrated by an in vitr
Autor:
Jennifer Law, Sandra E. Dunn, Nicole Couto, Amarpal S. Cheema, John A. Hassell, Karen Jung, Kristen Reipas, Steven J.M. Jones, Yvonne Y. Li, Sumaiya A. Islam, Huifang Li, Artem Cherkasov
Publikováno v:
ResearcherID
Oncotarget
Oncotarget
// Kristen M. Reipas 1 , Jennifer H. Law 1 , Nicole Couto 1 , Sumaiya Islam 1 , Yvonne Li 2 , Huifang Li 3 , Artem Cherkasov 3 , Karen Jung 4 , Amarpal S. Cheema 1 , Steven J. M. Jones 2 , John A. Hassell 5 , Sandra E. Dunn 1 1 Laboratory for Oncogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e0e77c7c83b6cf319fc8543ad2af3e
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318782500019&KeyUID=WOS:000318782500019
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318782500019&KeyUID=WOS:000318782500019